
- Purity (HPLC)
- ≥ 98.8%
- Storage & stability
- Lyophilized: −20°C, protected from light.
- Current lot
- CJI-2501A
- Tested purity
- 98.8%
- COA
- Ships with order
- HPLC trace · lot CJI-2501A
A prepared 1:1 research blend of CJC-1295 (no DAC) and ipamorelin in a single vial, for laboratories studying combined GHRH-analog and ghrelin-receptor-agonist signaling in one preparation. Supplied as lyophilized powder for in-vitro laboratory research use only. Not for human or veterinary use, and not for use in food, drugs, medical devices, or cosmetics.
Selected literature (2)
- Teichman et al. — GHRH analog pharmacology (CJC-1295)
- Raun et al. — Ipamorelin, a selective ghrelin-receptor agonist
Citations describe published research on this compound and are provided for scientific reference only — they are not claims about this product.
Research use only. This material is sold for in-vitro laboratory research and development purposes exclusively. It is not a drug, food, or dietary supplement, has not been evaluated by the FDA, and must not be used in humans or animals.